Advertisement
Advertisement
June 7, 2015
Cordis Launches EliteCross and Outback Elite CTO Devices
June 8, 2015—Cordis Corporation announced the launch of the EliteCross support catheter in the United States and the launch of the Outback Elite re-entry catheter in the United States, Europe, and Japan. These new products in the Cordis portfolio of crossing devices for the treatment of chronic total occlusions (CTOs) in peripheral artery disease add to a suite of specialty and workhorse solutions designed to support physicians in crossing the most complex lesions. The EliteCross support catheter will be launched in Europe and Japan in the coming months, advised Cordis.
In the company’s press release, J.A. Mustapha, MD, commented, “New and dedicated CTO crossing wires, re-entry devices, and crossing catheters, combined with advancing technique, have led to a significant improvement in success rates of CTO treatment in recent years. The expanded Cordis crossing portfolio enables physicians to further improve treatment success and deliver the best possible care to the patients that rely on us every day.” Dr. Mustapha is Director of Heart and Vascular at Metro Health Hospital in Wyoming, Michigan.
According to Cordis, the new EliteCross support catheter features a braided shaft, tapered tip, lubricious hydrophilic coating, and ultra-low-friction inner lumen to enhance trackability over the guidewire. The device is designed to provide additional support to the distal portion of diagnostic or interventional devices and is compatible with the FrontRunner XP CTO catheter, as well as other ancillary devices.
The redesigned Outback Elite re-entry catheter enables faster and more precise re-entry into the true lumen in the most challenging cases. The device’s redesign is focused on providing control and precision with an ergonomic handle and torque control location that enables single-handed operation by the user. The addition of an 80-cm shaft length will aid in optimizing procedures by reducing the length of shaft outside the patient. These new features are combined with a redesigned package, stated Cordis Corporation.
Advertisement
Advertisement